Correction: A novel biocompatible,simvastatin-loaded,bone-targeting lipid nanocarrier for treating osteoporosis more effectively

Correction for ‘A novel biocompatible, simvastatin-loaded, bone-targeting lipid nanocarrier for treating osteoporosis more effectively’ by Shan Tao et al., RSC Adv., 2020, 10, 20445–20459, DOI: 10.1039/D0RA00685H.

The authors regret that incorrect versions of Fig. 7, ​,99 and ​and1010 were included in the original article. The correct versions of Fig. 7, ​,99 and ​and1010 are presented below.Open in a separate windowFig. 7Histological analysis of organs from all experimental groups. H&E staining of heart, liver, spleen, lung, kidney, indicating the carrier has good biocompatibility. Scale bar = 50 μm.Open in a separate windowFig. 9Alkaline phosphatase (ALP) activity (arrows) and tartrate-resistant acid phosphatase (TRAP) assay results (arrowheads) of bone tissue sections. Scale bar = 50 μm. The ALP activity is much more high in SIM/LNPs and SIM/ASP₆-LNPs groups, while the TRAP activity is the opposite.Open in a separate windowFig. 10Histological assessment of bone formation in all experimental groups. (A) HE staining of femur bone. Scale bar = 50 μm. Histology of bone in the all experimental groups shows all ovariectomized groups had a higher amount of adipose tissue than Sham group. The trabecular bone is much more prominent in SIM/LNPs and SIM/ASP₆-LNPs groups. (B) Immunohistochemical staining for BMP-2 in typical newly-formed bone tissue (red arrows) and immunohistochemical staining for the osteogenic markers osteopontin (OPN, arrows) and osteocalcin (OCN, arrowheads). Scale bar = 50 μm. The BMP-2, OPN, OCN are much more prominent in SIM/LNPs and SIM/ASP₆-LNPs groups.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Chrysomycins A–C,antileukemic naphthocoumarins from Streptomyces sporoverrucosus

Correction for ‘Chrysomycins A–C, antileukemic naphthocoumarins from Streptomyces sporoverrucosus’ by Shreyans K. Jain et al., RSC Adv., 2013, 3, 21046–21053, https://doi.org/10.1039/c3ra42884b.

The authors regret that incorrect versions of Fig. 6 and Fig. 7 were included in the original article. The correct versions of Fig. 6 and ​and77 are presented below.Open in a separate windowFig. 6Influence of compounds 1–3 on the nuclear morphology of human leukaemia HL-60 cells. The cells were treated with 1, 3 and 5 μM concentrations of these compounds for 24 h and stained with Hoechst 33258 for 40 min. The altered nuclear morphology and apoptotic bodies indicated by white arrows are seen in treated cells while the nuclei of the untreated cells were round and intact.Open in a separate windowFig. 7Phase contrast microscopy of compound-treated leukaemia HL-60 cells. Cells were treated with compounds 1–3 at 1, 3 and 5 μM for 24 h and visualized using a phase contrast microscope (Olympus1X72). The morphology of treated cells altered in a concentration-dependent manner, while the untreated cells remained healthy.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Synthesis and characterization of AFe2O4 (A: Ni,Co, Mg)–silica nanocomposites and their application for the removal of dibenzothiophene (DBT) by an adsorption process: kinetics,isotherms and experimental design

Correction for ‘Synthesis and characterization of AFe₂O₄ (A: Ni, Co, Mg)–silica nanocomposites and their application for the removal of dibenzothiophene (DBT) by an adsorption process: kinetics, isotherms and experimental design’ by Fahimeh Vafaee et al., RSC Adv., 2021, 11, 22661–22676, https://doi.org/10.1039/D1RA02780H.

The authors regret an error in Fig. 4 where a section of the XRD for 4(a) and (b) is identical.Open in a separate windowFig. 4(a) The XRD pattern of sample 3 after adsorption of DBT. (b) The XRD pattern of sample 3 before adsorption of DBT.The authors have repeated the experiment and provided new data for Fig. 4. An independent expert has viewed the new data and has concluded that it is consistent with the discussions and conclusions presented. The correct Fig. 4 is shown below:The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Efficient removal of cobalt from aqueous solution using β-cyclodextrin modified graphene oxide

Correction for ‘Efficient removal of cobalt from aqueous solution using β-cyclodextrin modified graphene oxide’ by Wencheng Song et al., RSC Adv., 2013, 3, 9514–9521.

The authors regret that Fig. 1 and ​and33 were incorrect in the original article. The SEM images of both GO and β-CD, and the Raman spectra of both, were confused with other samples. The correct versions of Fig. 1 and ​and33 are presented below.Open in a separate windowFig. 1SEM images of (a) GO and (b) β-CD-GO.Open in a separate windowFig. 2Raman spectra of GO and β-CD-GO.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Green-synthesised cerium oxide nanostructures (CeO2-NS) show excellent biocompatibility for phyto-cultures as compared to silver nanostructures (Ag-NS)

Correction for ‘Green-synthesised cerium oxide nanostructures (CeO₂-NS) show excellent biocompatibility for phyto-cultures as compared to silver nanostructures (Ag-NS)’ by Qaisar Maqbool, RSC Adv., 2017, 7, 56575–56585, https://doi.org/10.1039/c7ra12082f.

The author regrets that Fig. 4 and ​and55 of the original article did not appropriately represent the findings.Open in a separate windowFig. 4Comparative TGA analysis of CeO₂-NS and Ag-NS.Open in a separate windowFig. 5FTIR spectrum of CeO₂-NS and Ag-NS.The correct version of Fig. 4 is shown below. In addition, the associated text on page 56578 “Experimental findings show total mass loss…” should be changed to “Experimental findings show total mass loss of 57.53% by CeO₂-NS and 61.12% by Ag-NS.” Fig. 5 of the original article shows only the plot of selected data points. In order to provide clarity to readers, it should be replaced with the following original FTIR plots (complete scan).The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Hybrid cellulose nanocrystal/alginate/gelatin scaffold with improved mechanical properties and guided wound healing

Correction for ‘Hybrid cellulose nanocrystal/alginate/gelatin scaffold with improved mechanical properties and guided wound healing’ by Yue Shan et al., RSC Adv., 2019, 9, 22966–22979, https://doi.org/10.1039/C9RA04026A.

The authors regret that incorrect versions of Fig. 7 and ​and88 were included in the original article. The correct versions of Fig. 7 and ​and88 are presented below.Open in a separate windowFig. 7H&E staining images in control, SA/Ge, and SA/Ge/CNC groups at 7 days and 14 days after surgery. The bar corresponds to 50 μm.Open in a separate windowFig. 8Masson’s trichrome staining images in control, SA/Ge, and SA/Ge/CNC groups at 7 and 14 days after surgery. The bar corresponds to 50 μm.An independent expert has viewed the corrected images/data and has concluded that they are consistent with the discussions and conclusions presented.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Photodynamic antimicrobial chemotherapy with cationic phthalocyanines against Escherichia coli planktonic and biofilm cultures

Correction for ‘Photodynamic antimicrobial chemotherapy with cationic phthalocyanines against Escherichia coli planktonic and biofilm cultures’ by Min Li et al., RSC Adv., 2017, 7, 40734–40744, https://doi.org/10.1039/C7RA06073D.

The authors regret that incorrect versions of Fig. 7F (Control) and Fig. 8A (Light-alone) were included in the original article. The corrected versions are shown below. The correction does not change any results or conclusions of the original paper.Open in a separate windowFig. 7Membrane integrity detected by PI staining. (F) Images taken by fluorescence microscope of E. coli treated with 5 μM ZnPc2 in different groups.Open in a separate windowFig. 8SEM images of PACT-subjected E. coli biofilms. (A) Images of E. coli treated with 20 μM ZnPc1-PACT in different groups.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Bio-conjugation of graphene quantum dots for targeting imaging

Correction for ‘Bio-conjugation of graphene quantum dots for targeting imaging’ by Fei Jia et al., RSC Adv., 2017, 7, 53532–53536.

The authors regret that the versions of Fig. 2 and ​and44 displayed in the original article were incorrect. The loading dye in Fig. 2c should be the artificial marker for molecular weight analysis. The original Fig. 4 did not support the EGFR binding due to the cell endocytosis, and the result has been revised with an improved data set. The correct versions of Fig. 2 and ​and44 are shown below.Open in a separate windowFig. 2(a) The sucrose DGU gradient used for purifying the conjugates. (b) The desired SA@GQDs positions in the DGU column. (c) PL image of the DGU column after ultracentrifuge. (d) Bolt 4–12% Bis–Tris gel electrophoresis analysis of SA@GQDs, anti-mouse@GQDs and Erbitux@GQDs, respectively. The loading dye with confirmed molecule weight was tested as references. (e) The cell viability of conjugate Erbitux@GQDs (SCC cell).Open in a separate windowFig. 4(a) SCC cell imaging by Erbitux@GQDs which is binding to the EGFR receptor of SCC cell membrane. (b) The bright field, and PL picture at different channels. After merging the PL picture of Dapi and GFP channels, the successful staining of membrane and nucleus was observed. The quantum yield of GQDs is much lower than Dapi, and we have to tune the contrast/brightness to reach the same quality between Dapi and GQDs. The emission of Dapi also has some signal in GQDs channel, and we have re-draw the data to get rid of the Dapi signal.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: A p-type multi-wall carbon nanotube/Te nanorod composite with enhanced thermoelectric performance

Correction for ‘A p-type multi-wall carbon nanotube/Te nanorod composite with enhanced thermoelectric performance’ by Dabin Park et al., RSC Adv., 2018, 8, 8739–8746.

The authors regret that an incorrect version of Fig. 8 was included in the original article. The correct version of Fig. 8 is presented below.Open in a separate windowFig. 1FE-SEM images of MWCNT/Te nanorod composites with various MWCNT contents (a) 1 wt%, (b) 3 wt%, and (c) 5 wt%.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Synthesis of non-toxic,biocompatible, and colloidal stable silver nanoparticle using egg-white protein as capping and reducing agents for sustainable antibacterial application

Correction for ‘Synthesis of non-toxic, biocompatible, and colloidal stable silver nanoparticle using egg-white protein as capping and reducing agents for sustainable antibacterial application’ by Kalaiyarasan Thiyagarajan et al., RSC Adv., 2018, 8, 23213–23229, DOI: 10.1039/C8RA03649G.

The authors regret that an incorrect version of Fig. 3(D) was included in the original article. The correct version of Fig. 3(D) is presented below.Open in a separate windowFig. 3(D) TEM image of AgNPs-EW after freeze-drying.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Facile one-pot synthesis of silver nanoparticles encapsulated in natural polymeric urushiol for marine antifouling

Correction for ‘Facile one-pot synthesis of silver nanoparticles encapsulated in natural polymeric urushiol for marine antifouling’ by Lu Zheng et al., RSC Adv., 2020, 10, 13936–13943, DOI: 10.1039/D0RA02205E.

The authors regret that an incorrect version of Fig. 2 was included in the original article. The correct version of Fig. 2 is presented below.Open in a separate windowFig. 2TEM images of PUL/AgNPs (a–d); EDS of AgNPs (e); UV-vis spectra of AgNPs (f); FT-IR spectra of urushiol (U); PUL/AgNPs (g); XRD image of AgNPs (h).The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Discovery of 8-prenylnaringenin from hop (Humulus lupulus L.) as a potent monoacylglycerol lipase inhibitor for treatments of neuroinflammation and Alzheimer’s disease

Correction for ‘Discovery of 8-prenylnaringenin from hop (Humulus lupulus L.) as a potent monoacylglycerol lipase inhibitor for treatments of neuroinflammation and Alzheimer’s disease’ by Min-Che Tung et al., RSC Adv., 2021, 11, 31062–31072, https://doi.org/10.1039/D1RA05311F.

The authors regret that the name of one of the authors (Hsing-Mien Hsu) was shown incorrectly in the original article. The corrected author list is as shown above.The authors also regret an incorrect version of Fig. 7 was included in the original article. The correct version of Fig. 7 is presented below.Open in a separate windowFig. 7The dose-dependent inhibitions of the identified inhibitors against hMAGL.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: The corrosion behaviors of multilayer diamond-like carbon coatings: influence of deposition periods and corrosive medium

Correction for ‘The corrosion behaviors of multilayer diamond-like carbon coatings: influence of deposition periods and corrosive medium’ by Mingjun Cui et al., RSC Adv., 2016, 6, 28570–28578, DOI: 10.1039/C6RA05527C.

The authors regret that an incorrect version of Fig. 3 was included in the original article. The correct version of Fig. 3 is shown below.Open in a separate windowFig. 3SEM images of surface morphology of multilayer DLC coatings. (a) 5 deposition periods, (b) 12 deposition periods, (c) 15 deposition periods, (d) 20 deposition periods.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: iTRAQ-based quantitative proteomic analysis for identification of biomarkers associated with emodin against severe acute pancreatitis in rats

Correction for ‘iTRAQ-based quantitative proteomic analysis for identification of biomarkers associated with emodin against severe acute pancreatitis in rats’ by Hong Xiang et al., RSC Adv., 2016, 6, 72447–72457.

The authors regret that Fig. 2–4 were shown incorrectly in the original article. An incorrect section of the SAP group in the MPO-immunohistochemical staining (Fig. 2A) and HE staining (Fig. 3) experiments was used in error. In addition, Fig. 4 has been revised to show the zymogen granule, in order to better represent the ultrastructure of the pancreas. The correct versions of Fig. 2–4 are shown below.Open in a separate windowFig. 2Emodin down-regulated the MPO protein expression in pancreas of SAP rats. (A) Effect of emodin on MPO-immunopositive area (brown) staining of pancreatic tissue in SAP rats by immunohistochemical detection. (B) Effect of emodin on MPO-immunopositive area (red) staining of pancreatic tissue in SAP rats by immunofluorescence detection. Images are presented at 200× magnification. The data are presented as the mean ± SD, n = 6. **P < 0.01 versus SO; ^#P < 0.05 versus SAP, ^##P < 0.01 versus SAP.Open in a separate windowFig. 3Emodin improved pancreatic histopathology of SAP rats. Effect of emodin on H&E staining of pancreatic tissue in SAP rats. Images are presented at 200× magnification. The data are presented as the mean ± SD, n = 6. **P < 0.01 versus SO; ^#P < 0.05 versus SAP, ^##P < 0.01 versus SAP.Open in a separate windowFig. 4Emodin attenuated cellular structure changes in pancreas of SAP rats. Representative images of the cells’ ultrastructure in the SO (A), SAP (B), 60 mg kg⁻¹ emodin (C), 30 mg kg⁻¹ emodin (D) and 15 mg kg⁻¹ emodin (E) groups. Images are presented at 25 000× magnification.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Preparation of a novel curcumin nanoemulsion by ultrasonication and its comparative effects in wound healing and the treatment of inflammation

Correction for ‘Preparation of a novel curcumin nanoemulsion by ultrasonication and its comparative effects in wound healing and the treatment of inflammation’ by Niyaz Ahmad et al., RSC Adv., 2019, 9, 20192–20206, DOI: 10.1039/C9RA03102B.

The authors regret errors in Fig. 7 in the original article. The corrected Fig. 7 is shown below where the panels at 8 and 12 days for fusidic acid and 16 and 20 days for Cur-NE have been replaced.Open in a separate windowFig. 7Wound healing effects of optimized nanoemulsion without Cur loaded; pure clove oil; pure Cur-S; optimized nanoemulsion and marketed preparation of antibiotic fusidic acid (Fusidin; positive control) in comparison with the control after 0, 4, 8, 12, 16, 20 and 24 days of inducing wound healing.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.     

Correction: Noninvasive target CT detection and anti-inflammation of MRSA pneumonia with theranostic silver loaded mesoporous silica

Correction for ‘Noninvasive target CT detection and anti-inflammation of MRSA pneumonia with theranostic silver loaded mesoporous silica’ by Hao Zhang et al., RSC Adv., 2016, 6, 5049–5056.

The authors regret that an incorrect version of Fig. 1 was included in the original article. The correct version of Fig. 1 is presented below.Open in a separate windowFig. 1(A) SEM image of PEGylated SLS NPs; inset: high-resolution TEM image highlighting the anchored Ag NPs. (B) XPS result of the SLS NPs and silver element. (C) DLS and zeta-potential profiles of the SLS NPs pre- and post-PEGylation.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.